Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Collagenase in Adhesive Capsulitis
NCT00261196Phase 2Withdrawn
- Sponsor
- Stony Brook University
- Start
- Jan 2006
- Primary completion
- Jan 2009
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in adhesive capsulitis (AC) comparing Collagenase with Placebo (2 arms). Primary endpoint: Active elevation of the affected shoulder at 30 days. Planned start Jan 2006; status: withdrawn.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
adhesive capsulitis (AC)
Beyond the preview
Go deeper on NCT00261196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00261196.